| Literature DB >> 32448328 |
Buli Su1, Dandan Song1, Honghui Zhu2.
Abstract
BACKGROUND: Metabolic engineering frequently needs genomic integration of many heterologous genes for biosynthetic pathway assembly. Despite great progresses in genome editing for the model microorganism Escherichia coli, the integration of large pathway into genome for stabilized chemical production is still challenging compared with small DNA integration.Entities:
Keywords: CRISPR-Cas9; Chromosomal integration; Escherichia coli; Lambda Red; Metabolic engineering
Mesh:
Year: 2020 PMID: 32448328 PMCID: PMC7245811 DOI: 10.1186/s12934-020-01360-x
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Outline of the λ-Red assisted homology-dependent recombination for large synthetic pathways integration in Escherichia coli. a Construction of plasmid pRC-IS5 with large synthetic pathways. pRC-IS5 (including R6K and a homologous region) replicates normally in E. coli with the expression of pir + protein and the plasmid replication was restricted in normal E. coli. b Single-crossover HDR assisted by λRed. The vector pRC-IS5 was introduced into the host which harbored pCas with the expression of Exo, Beta, and Gam, and then selection was conducted with the addition of chloramphenicol. Single crossover produced homology-dependent insertion events, where the entire vector pRC-IS5 was integrated into the chromosome at the target locus. A simple screening step by PCR diagnosis could identify the desired mutant. c Deleting redundant sequences assisted by λ-Red. The gRNA plasmid pTargetF-delete and the donor template were electroporated into the competent cells harbored plasmid pCas with the expression of Cas9 nuclease and λ-Red protein, and then the selection was carried out using kanamycin and spectinomycin. λ-Red mediated deletion at the lagging strand of the replication fork produced homologous recombination, where the redundant sequences were deleted
Fig. 2a MEP pathway and related metabolism showing the major metabolic regulatory points. d-glyceraldehyde 3-phosphate (G-3P);1-deoxy-d-xylulose 5-phosphate (DXP); methylerythritol 4-phosphate (MEP); diphosphocytidyl methylerythritol (CDP-ME); diphosphocytidyl methylerythritol 2-phosphate (CDP-MEP); hydroxymethylbutenyl diphosphate (HMBPP); isopentenyl diphosphate (IPP); dimethylallyl diphosphate (DMAPP); farnesyl diphosphate (FPP). b The limiting step for lycopene production was divided into three modules. The feedforward module including dxs and dxr, feedback module including idi and crtE and lycopene synthetic module including crtI, crtE and crtB for lycopene production
Fig. 3Promoters characterization of three modules for lycopene biosynthesis. a Selection promoters for lycopene synthetic modules (including crtI, crtE and crtB). Lycopene synthetic modules were overexpressed in E. coli W3110 with the native MEP pathway. trc, EC101; yciG, EC102; pstA, EC103; yodA, EC104; astC, EC105; ybiM, EC106. b Selection promoters for feedforward modules (including dxs and dxr). Feedforward modules were overexpressed along with lycopene synthetic modules. phnI, EC201; phoR, EC202; phnF, EC203; phnC, EC204; phnD, EC205. c Selection promoters for feedback modules (including idi and crtE). Feedback modules were overexpressed along with lycopene synthetic modules. yfiL, EC301; yijF, EC302; cysP, EC303; yeiG, EC304; yhcN, EC305. Each value represents the average ± SD of three biological replicates
Fig. 4Integration of a 12 kb DNA module into E. coli W3110 genome. a The optimized lycopene synthetic pathways in pRC-IS5. b Colony forming unit (CFU, indicated the number of colonies on the selective plates with 34 μg mL−1 chloramphenicol after one experiment of integrating optimized lycopene synthetic pathways into E. coli W3110) and integration efficiency with or without adding arabinose to induce λ-Red. c PCR confirmation of the integration of the optimized lycopene synthetic pathways using primers IS5-Q-P1 and dxs-dxr-P2 for feedforward module (6521 bp), IEB-P1 and IS5-Q-P2 for lycopene synthetic module (4811 bp), idi-crtE-P1 and idi-crtE-P2 for feedback module (3042 bp). M: DNA marker; CK: E. coli W3110; 1, 2, 3, 4, 5, 6: colonies from the plates after chromosomal integration
Fig. 5Deletion of redundant sequences with CRISPR-Cas9 system. a PCR confirmation of the deletion of redundant sequences using primers IS5-check-P1 and IS5-check-P2. The decrescent bands indicated the successful deletion of redundant sequences. M: DNA marker; CK: strain without deletion of redundant sequences; 1,2,3,4,5,6,7,8,9: colonies from the plate after editing using CRISPR-Cas9 system. b The lycopene yields of shake flask fermentation of strain EC101, EC-IS5, EC401 and EC-IS5 (ΔCm). Each value represents the average ± SD of three biological replicates
Methods for the integration of large DNA module into E. coli chromosome
| Method | Technique feature | Integration efficiency (%) | Integration sites | Maximum integration size (kb) | Rounds of integration | Marker left or | Reference |
|---|---|---|---|---|---|---|---|
| I-SceI endonuclease | Combined λ-Red and I-SceI Cleavage | 19.2–100 | Desired locus | 7 | One | Markerless | [ |
| λ-Red recombination | λ-Red assisted | 0–50 | Desired locus | 7.3 | One | Markerless | [ |
| λ-Red recombination | Combined λ-Red and CRISPR/Cas9 | 10 | Desired locus | 7 | One | Markerless | [ [ |
| 60 | 15.4 | Five | Markerless | ||||
| λ-Red recombination | λ-Red assisted | Not provide | 15 | Four | Markerless | ||
| Not provide | 50 | Seven | Markerless | ||||
| CRISPR/Cas9 | Combined λ-Red and CRISPR/Cas9 | 60 | Desired locus | 7 | One | Markerless | [ |
| CRISPR/Cas9 | Combined λ-Red and CRISPR/Cas9 | 50 | Desired locus | 10 | One | Markerless | [ |
| RecA homologous recombination | Combined λ-Red, RecA and CRISPR/Cas9 | 100 | 12 | One | Markerless | This study |
Escherichia coli strains and plasmids used in this study
| Strain/plasmid | Description | Source |
|---|---|---|
| DH5ɑ | Invitrogen | |
| DH5α λpir | Lab stock | |
| W3110 | Wide type, | DSM5911 |
| EC101 | W3110 with plasmid pET-trc-IEB | This study |
| EC102 | W3110 with plasmid pCDF-yciG-IEB | This study |
| EC103 | W3110 with plasmid pCDF-pstA-IEB | This study |
| EC104 | W3110 with plasmid pCDF-yodA-IEB | This study |
| EC105 | W3110 with plasmid pCDF-astC-IEB | This study |
| EC106 | W3110 with plasmid pCDF-ybiM-IEB | This study |
| EC201 | W3110 with plasmid pACYC-phnI | This study |
| EC202 | W3110 with plasmid pACYC-phoR | This study |
| EC203 | W3110 with plasmid pACYC-phnF | This study |
| EC204 | W3110 with plasmid pACYC-phnC | This study |
| EC205 | W3110 with plasmid pACYC-phnD | This study |
| EC301 | W3110 with plasmid pACYC-yfiL | This study |
| EC302 | W3110 with plasmid pACYC-yijF | This study |
| EC303 | W3110 with plasmid pACYC-cysP | This study |
| EC304 | W3110 with plasmid pACYC-yejG | This study |
| EC305 | W3110 with plasmid pACYC-yhcN | This study |
| EC401 | DH5α λpir with plasmid pRC-IS5 | This study |
| EC-IS5 | W3110 with the integration of plasmid pRC-IS5 | This study |
| EC-IS5(ΔCm) | EC-IS5 with the deletion of | This study |
| pCDFDuet-1 | pCloDF13-derived vector; T7 promoter, StrR | Lab stock |
| pET-30a-trc | pBR322-derived vector; trc promoter, KmrR | Lab stock |
| pACYCDuet-1 | p15A-derived vector; T7 promoter, CmrR | Lab stock |
| pTrc99a | pBR322-derived vector; trc promoter, AmpR | [ |
| pRC43 | Including R6K ori, | [ |
| pCas | [ | |
| pTargetF-cadA | pMB1 aadA sgRNA-cadA | [ |
| pET-trc-IEB | Lycopene synthetic module under the trc promoter | This study |
| pCDF-yciG-IEB | Lycopene synthetic module under the yciG promoter | This study |
| pCDF-pstA-IEB | Lycopene synthetic module under the pstA promoter | This study |
| pCDF-yodA-IEB | Lycopene synthetic module under the yodA promoter | This study |
| pCDF-astC-IEB | Lycopene synthetic module under the astC promoter | This study |
| pCDF-ybiM-IEB | Lycopene synthetic module under the ybiM promoter | This study |
| pACYC-phnI | Lycopene synthetic module under the yciG promoter, feedforward module under the phnI promoter | This study |
| pACYC-phoR | Lycopene synthetic module under the yciG promoter, feedforward module under the phoR promoter | This study |
| pACYC-phnF | Lycopene synthetic module under the yciG promoter, feedforward module under the phnF promoter | This study |
| pACYC-phnC | Lycopene synthetic module under the yciG promoter, feedforward module under the phnC promoter | This study |
| pACYC-phnD | Lycopene synthetic module under the yciG promoter, feedforward module under the phnD promoter | This study |
| pACYC-yfiL | Lycopene synthetic module under the yciG promoter, feedback module under the yfiL promoter | This study |
| pACYC-yijF | Lycopene synthetic module under the yciG promoter, feedback module under the yijF promoter | This study |
| pACYC-cysP | Lycopene synthetic module under the yciG promoter, feedback module under the cysP promoter | This study |
| pACYC-yejG | Lycopene synthetic module under the yciG promoter, feedback module under the yejG promoter | This study |
| pACYC-yhcN | Lycopene synthetic module under the yciG promoter, feedback module under the yhcN promoter | This study |
| pTargetF-delete | gRNA for N20PAM | This study |
| pRC-IS5 | Including R6K ori, | This study |
a AmpR: ampicillin; KanR: kanamycin; StrR: Streptomycin; Cm: chloramphenicol; R:resistance